$ALDX News Article - Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 TRANQUILITY?2 Trial in Dry Eye Disease and Intends to Submit New Drug Application for Symptoms and Three Sign Endpoints of Dry Eye Disease
https://marketwirenews.com/news-releases/alde...36511.html